Gene · 1785
Papers3,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ellagic Acid Triggers the Necrosis of Differentiated Human Enterocytes Exposed to 3-Nitro-Tyrosine: An MS-Based Proteomic Study. | Antioxidants (Basel) | 2022 | 36552693 | PubTator, text mining | PubMed |
| Current Insights in the Mechanisms of Cobra Venom Cytotoxins and Their Complexes in Inducing Toxicity: Implications in Antivenom Therapy. | Toxins (Basel) | 2022 | 36548736 | PubTator, text mining | PubMed |
| Delivery of Melittin as a Lytic Agent via Graphene Nanoparticles as Carriers to Breast Cancer Cells. | J Funct Biomater | 2022 | 36547538 | PubTator, text mining | PubMed |
| Genetic-Based Treatment Strategies for Muscular Dystrophy and Congenital Myopathies. | Continuum (Minneap Minn) | 2022 | 36537981 | PubTator, text mining | PubMed |
| The human cytomegalovirus decathlon: Ten critical replication events provide opportunities for restriction. | Front Cell Dev Biol | 2022 | 36506089 | PubTator, text mining | PubMed |
| MiR-199a-3p Induces Mesenchymal to Epithelial Transition of Keratinocytes by Targeting RAP2B. | Int J Mol Sci | 2022 | 36499729 | PubTator, text mining | PubMed |
| Role of Ceramides and Lysosomes in Extracellular Vesicle Biogenesis, Cargo Sorting and Release. | Int J Mol Sci | 2022 | 36499644 | PubTator, text mining | PubMed |
| Targeting Mitochondrial Dynamics Proteins for the Development of Therapies for Cardiovascular Diseases. | Int J Mol Sci | 2022 | 36499064 | PubTator, text mining | PubMed |
| Vasopressin induces apoptosis but does not enhance the antiproliferative effect of dynamin 2 or PI3K/Akt inhibition in luminal A breast cancer cells. | Med Oncol | 2022 | 36460880 | PubTator, text mining | PubMed |
| An ER phospholipid hydrolase drives ER-associated mitochondrial constriction for fission and fusion. | Elife | 2022 | 36448541 | PubTator, text mining | PubMed |
| Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer. | Exp Mol Med | 2022 | 36446847 | PubTator, text mining | PubMed |
| The molecular organization of differentially curved caveolae indicates bendable structural units at the plasma membrane. | Nat Commun | 2022 | 36433988 | PubTator, text mining | PubMed |
| Learning from TCR Signaling and Immunological Synapse Assembly to Build New Chimeric Antigen Receptors (CARs). | Int J Mol Sci | 2022 | 36430728 | PubTator, text mining | PubMed |
| Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia? | Cancers (Basel) | 2022 | 36428753 | PubTator, text mining | PubMed |
| Skeletal and cardiac muscle calcium transport regulation in health and disease. | Biosci Rep | 2022 | 36413081 | PubTator, text mining | PubMed |
| Recent progress in epigenetics of obesity. | Diabetol Metab Syndr | 2022 | 36397166 | PubTator, text mining | PubMed |
| Cortactin: A universal host cytoskeletal target of Gram-negative and Gram-positive bacterial pathogens. | Mol Microbiol | 2022 | 36396951 | PubTator, text mining | PubMed |
| PRDX1 Influences The Occurrence and Progression of Liver Cancer by Inhibiting Mitochondrial Apoptosis Pathway. | Cell J | 2022 | 36377215 | PubTator, text mining | PubMed |
| Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy. | Nat Commun | 2022 | 36369230 | PubTator, text mining | PubMed |
| Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology. | Pharmaceutics | 2022 | 36365206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1785/papers?page=17